Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Veridian Healthcare
EIR
•Veridian Healthcare•November 28, 2018

Veridian Healthcare – FDA EIR, Nov 28, 2018

Record Details

An FDA inspection of Veridian Healthcare, an own-label distributor of OTC topical analgesic drug products and medical devices located in Gurnee, IL, was conducted from November 15-28, 2018. This initial cGMP inspection, focusing on quality, facilities, equipment, materials, and production systems, resulted in a 5-observation FDA Form 483. The inspection revealed significant deficiencies in the company's quality management system. Veridian Healthcare's Quality Unit lacked the authority to review batch production records from its contract manufacturer, hindering full investigation of potential errors. The Quality Unit also failed to follow established written procedures, particularly regarding the timely closure of complaints. Complaint investigations were deemed inadequate, with instances where necessary follow-up with the contract manufacturer was not initiated despite sufficient information. Crucially, the firm failed to identify and report Adverse Drug Events to the FDA for product-related injuries, and it lacked a dedicated written recall procedure for drug products, relying on a medical device procedure instead. Discussions with management also highlighted unupdated written procedures for drug products, inconsistent documentation practices, and a Quality Agreement missing assignments for adverse drug event reporting, retain sample retention, supplier auditing, and stability testing. The firm's registration status as a drug repackager was also noted as inaccurate for its operations. Veridian Healthcare's management acknowledged the findings and committed to a written response to the FDA within 15 business days, outlining plans to correct all identified issues within six months. This includes updating all relevant procedures for drug products, improving complaint investigation processes, performing an audit of their contract manufacturer, and revising the Quality Agreement to clearly define responsibilities.

Company
Veridian Healthcare
Inspection date
November 28, 2018
Product type
OTC (Over-the-Counter)
Office
Chicago District Office
Person
  • Michele L. Glendenning
View Company Profile

ID · bce8d778-37ad-4cc7-b3fe-cd90aafd92d3

Violation Codes4
21 CFR 820.19821 CFR 721 CFR 820.3(b)21 CFR 314.80

Full citation text and observation details available on the Dashboard.

Other documents for Veridian Healthcare
  • 483 - 2018-11-28November 28, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Veridian Healthcare
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.